ALPS Medical Breakthroughs ETF (SBIO)
NYSEARCA: SBIO · Real-Time Price · USD
51.07
-0.15 (-0.29%)
Jan 16, 2026, 4:00 PM EST - Market closed
SBIO Holdings Information
SBIO is an equity ETF with a total of 91 individual holdings. The top holdings are Kymera Therapeutics stock at 3.60%, Crinetics Pharmaceuticals at 3.43%, Structure Therapeutics at 3.31%, Alkermes at 3.30%, and Celcuity at 3.12%.
Total Holdings
91
Top 10 Percentage
31.09%
Asset Class
Equity
ETF Category
Health
Assets
131.05M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | KYMR | Kymera Therapeutics, Inc. | 3.60% |
| 2 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.43% |
| 3 | GPCR | Structure Therapeutics Inc. | 3.31% |
| 4 | ALKS | Alkermes plc | 3.30% |
| 5 | CELC | Celcuity Inc. | 3.12% |
| 6 | MIRM | Mirum Pharmaceuticals, Inc. | 3.04% |
| 7 | ACAD | ACADIA Pharmaceuticals Inc. | 2.88% |
| 8 | APGE | Apogee Therapeutics, Inc. | 2.84% |
| 9 | FOLD | Amicus Therapeutics, Inc. | 2.83% |
| 10 | CGON | CG Oncology, Inc. | 2.74% |
| 11 | NAMS | NewAmsterdam Pharma Company N.V. | 2.31% |
| 12 | VKTX | Viking Therapeutics, Inc. | 2.31% |
| 13 | IDYA | IDEAYA Biosciences, Inc. | 2.02% |
| 14 | XENE | Xenon Pharmaceuticals Inc. | 2.02% |
| 15 | TARS | Tarsus Pharmaceuticals, Inc. | 2.00% |
| 16 | VERA | Vera Therapeutics, Inc. | 1.90% |
| 17 | EWTX | Edgewise Therapeutics, Inc. | 1.81% |
| 18 | DNLI | Denali Therapeutics Inc. | 1.77% |
| 19 | IRON | Disc Medicine, Inc. | 1.72% |
| 20 | APLS | Apellis Pharmaceuticals, Inc. | 1.66% |
| 21 | SYRE | Spyre Therapeutics, Inc. | 1.65% |
| 22 | TVTX | Travere Therapeutics, Inc. | 1.63% |
| 23 | MLYS | Mineralys Therapeutics, Inc. | 1.59% |
| 24 | OLMA | Olema Pharmaceuticals, Inc. | 1.47% |
| 25 | SRPT | Sarepta Therapeutics, Inc. | 1.43% |
As of Jan 15, 2026